Japanese health officials are reportedly investigating whether researchers fabricated data in a 2.8 billion yen ($21.12 million) Alzheimer’s drug trial.
According to Japan Today:
Health officials said they were questioning researchers after being told false data was used in clinical testing for the 2.8 billion yen government-backed Alzheimer’s study, aimed at improving diagnosis of the disease. Continue reading Japan officials allege data cooking in Alzheimer’s drug study